Latham-based medical technology company AngioDynamics is ramping up marketing of its NanoKnife cancer treatment machine after receiving approval from the U.S. Food and Drug Administration for its use ...
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...
In one analysis, 16% of men with no suspicious lesions on MRI had clinically significant prostate cancer identified after ...
Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback